Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 180

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 180
---
 Registration Statement. The rules and regulations of the SEC allow us to omit certain information from this prospectus that is
included in the Registration Statement. Statements made in this prospectus concerning the contents of any contract, agreement or other
document are summaries of all material information about the documents summarized, but are not complete descriptions of all terms of
these documents. If we filed any of these documents as an exhibit to the Registration Statement, you may read the document itself for
a complete description of its terms.

We are subject to the periodic
reporting and other information requirements of the Exchange Act as applicable to a “Foreign Private Issuer,” and we will
file annual reports and other information from time to time with the SEC in accordance with such requirements. Our filings with the SEC
are also available to the public through the SEC’s website at www.sec.gov.

As a foreign private issuer,
we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements,
and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained
in Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial
statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.

We maintain a corporate website
at www.newgenivf.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.
We have included our website address in this prospectus solely as an inactive textual reference. We will post on our website any materials
required to be so posted on such website under applicable corporate or securities laws and regulations, including, posting any XBRL interactive
financial data required to be filed with the SEC and any notices of general meetings of our shareholders.

<div align='center'>106

22,027,500 Ordinary Shares

NewGenIvf Group Limited

PROSPECTUS

June 3, 2025

NEWGENIVF LIMITED</div>

| AUDITED CONSOLIDATED FINANCIAL STATEMENTS                                                                                  |     |     |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 1171)                                                   |     | F-2 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 6743)                                                   |     | F-4 |
| Consolidated Balance Sheets as of December 31, 2024 and